Literature DB >> 2972934

Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine.

C L Broekkamp1, S K Oosterloo, H H Berendsen, A M van Delft.   

Abstract

The influences of the indirect serotonin agonist fenfluramine (5; 10 mg/kg s.c.), the serotonin antagonist metergoline (5; 10 mg/kg s.c.) and the 5-HT1A agonist 8-OHDPAT (0.1; 0.2; 0.46 mg/kg s.c.) on haloperidol-induced catalepsy in rats or mice and on morphine-induced catalepsy in rats were studied. Morphine-induced catalepsy was enhanced by fenfluramine and attenuated by metergoline, whereas neither fenfluramine nor metergoline had any effect on haloperidol-induced catalepsy. 8-OHDPAT strongly antagonised catalepsy induced by morphine or haloperidol. We conclude that serotonergic transmission plays a major role in effectuating morphine catalepsy but not in effectuating haloperidol catalepsy. The antagonistic effect of 8-OHDPAT suggests a secondary, modulating role for 5-HT1A receptor mediated events in both types of catalepsy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972934     DOI: 10.1007/bf00174869

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy.

Authors:  J Maj; E Mogilnicka; B Przewlocka
Journal:  Pharmacol Biochem Behav       Date:  1975 Jan-Feb       Impact factor: 3.533

2.  Effect of drugs influencing central 5-hydroxytryptaminergic mechanisms on morphine-induced catalepsy in the rat.

Authors:  J J Balsara; J H Jadhav; M P Muley; A G Chandorkar
Journal:  J Pharm Pharmacol       Date:  1979-04       Impact factor: 3.765

3.  Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine.

Authors:  W Kostowski; W Gumulka; A Cxlonkowski
Journal:  Brain Res       Date:  1972-12-24       Impact factor: 3.252

4.  Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs.

Authors:  B A McMillen; S M Scott; E A Davanzo
Journal:  J Pharm Pharmacol       Date:  1988-12       Impact factor: 3.765

5.  Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy.

Authors:  J J Balsara; J H Jadhav; A G Chandorkar
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

6.  The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats.

Authors:  J Sarnek; L Baran
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1975       Impact factor: 4.291

7.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

8.  Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.

Authors:  D L Ceulemans; Y G Gelders; M L Hoppenbrouwers; A J Reyntjens; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Drug-induced penile erections in rats: indications of serotonin1B receptor mediation.

Authors:  H H Berendsen; C L Broekkamp
Journal:  Eur J Pharmacol       Date:  1987-03-31       Impact factor: 4.432

10.  Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

Authors:  P A Janssen; C J Niemegeers; F Awouters; K H Schellekens; A A Megens; T F Meert
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

View more
  13 in total

1.  Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat.

Authors:  M L Wadenberg
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.

Authors:  Marie-Bernadette Assié; Hélène Dominguez; Nathalie Consul-Denjean; Adrian Newman-Tancredi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-01       Impact factor: 3.000

3.  F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.

Authors:  R Depoortère; L Bardin; A L Auclair; M S Kleven; E Prinssen; F Colpaert; B Vacher; A Newman-Tancredi
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

Review 4.  Biochemical and behavioural properties of clozapine.

Authors:  D M Coward; A Imperato; S Urwyler; T G White
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.

Authors:  M L Wadenberg; S Ahlenius
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Roxindole, a potential antidepressant. I. Effect on the dopamine system.

Authors:  J Maj; K Kolodziejczyk; Z Rogóz; G Skuza
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.

Authors:  Mark S Kleven; Marie-Bernadette Assié; Cristina Cosi; Catherine Barret-Grévoz; Adrian Newman-Tancredi
Journal:  Psychopharmacology (Berl)       Date:  2004-09-24       Impact factor: 4.530

8.  Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.

Authors:  A V Kulikov; V G Kolpakov; G B Maslova; I Kozintsev; N K Popova
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 9.  5-HT1A receptor agonists: recent developments and controversial issues.

Authors:  J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

10.  Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.

Authors:  W R Prescott; L H Gold; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.